|
KIAA1012 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.46789999547303E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.34400000018076E-07 |
| Normal-vs-Stage2 |
1.778520E-03 |
| Normal-vs-Stage3 |
1.624850E-04 |
| Normal-vs-Stage4 |
1.4478999998957E-07 |
| Stage1-vs-Stage2 |
5.805400E-01 |
| Stage1-vs-Stage3 |
5.451600E-01 |
| Stage1-vs-Stage4 |
4.291500E-02 |
| Stage2-vs-Stage3 |
3.059800E-01 |
| Stage2-vs-Stage4 |
4.480200E-02 |
| Stage3-vs-Stage4 |
2.687000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.41729999853158E-08 |
| Normal-vs-AfricanAmerican |
6.23469999999626E-05 |
| Normal-vs-Asian |
3.10299999994879E-06 |
| Caucasian-vs-AfricanAmerican |
6.702400E-01 |
| Caucasian-vs-Asian |
2.627400E-01 |
| AfricanAmerican-vs-Asian |
1.693760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.19950005483815E-09 |
| Normal-vs-Female |
1.009790E-02 |
| Male-vs-Female |
5.921200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.427100E-04 |
| Normal-vs-Extreme_Weight |
4.73910000131639E-09 |
| Normal-vs-Obese |
1.003830E-04 |
| Normal-vs-Extreme_Obese |
3.978000E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.512400E-01 |
| Normal_Weight-vs-Obese |
7.208200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.473800E-01 |
| Extreme_Weight-vs-Obese |
1.365250E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.298400E-01 |
| Obese-vs-Extreme_Obese |
8.830400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.79630000000697E-05 |
| Normal-vs-Age(41-60Yrs) |
2.47310000000001E-05 |
| Normal-vs-Age(61-80Yrs) |
1.1021999979377E-08 |
| Normal-vs-Age(81-100Yrs) |
8.984100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.752800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.548800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.050600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.736400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.309800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.619000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.5289999962026E-08 |
| Normal-VS-Type2 PRCC |
4.06510000000582E-05 |
| Normal-VS-KIRP CIMP |
6.15050000000172E-05 |
| Normal-VS-Unclassified PRCC |
1.722130E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.902400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.654600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.111400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.106200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.724400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.355400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.7479000002929E-07 |
| Normal-vs-N1 |
3.18370000029766E-07 |
| Normal-vs-N2 |
2.446200E-04 |
| N0-vs-N1 |
7.249800E-01 |
| N0-vs-N2 |
4.224000E-01 |
| N1-vs-N2 |
4.605400E-01 |
|
|
